Advertisement

Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal

      This paper is only available as a PDF. To read, Please Download here.

      Background:

      Plasma homovanillic acid (HVA) has been used as a measure of central dopaminergic activity but the validity of this method continues to be investigated. We used single photon emission tomography (SPECT) assessment of the dopamine (DA) transporter for comparison with plasma HVA in subjects at varying stages of abstinence from cocaine.

      Methods:

      Nineteen subjects were studied in two separate treatment sites. Plasma HVA and methoxyhydroxyphenethyleneglycol (MHPG) were measured by gas chromatography-mass spectroscopy (GC-MS). The DA transporter was quantified using the SPECT ligand [123I]BCIT.

      Results:

      At 2 weeks of abstinence and beyond there was an increasing positive correlation between plasma HVA and the SPECT measurement of the DA transporter (V3″).

      Conclusions:

      Plasma HVA may be more likely to reflect DA transporter density in the striatum when there is not a major drug-related change in the DA system.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bacopoulos NG
        • Heninger GR
        • Roth RH
        Effects of haloperidol and probenecid on plasma and CSF dopamine metabolites in the rhesus monkey (Macacca mulatta).
        Life Sci. 1978; 23: 1805-1812
        • Bowers Jr, MB
        • Swigar ME
        • Jatlow PI
        • Goicoechea N
        Plasma catecholamine metabolites and early response to haloperidol.
        J Clin Psychiatry. 1984; 45: 248-251
        • Chang W-H
        • Chen T-Y
        • Lee C-F
        • Hung J-C
        • Hu W-H
        • Yeh E-K
        Plasma homovanillic acid levels and subtyping of schizophrenia.
        Psychiatry Res. 1988; 23: 239-244
        • Davila R
        • Manero E
        • Zumarraga M
        • Andia I
        • Schweitzer JW
        • Friedhoff AJ
        Plasma homovanillic acid as a predictor of response to neuroleptics.
        Arch Gen Psychiatry. 1988; 45: 564-567
        • Davis KL
        • Davidson M
        • Mohs RC
        • Kendler KS
        • Davis BM
        • Johns CA
        • et al.
        Plasma homovanillic acid concentration and the severity of schizophrenic illness.
        Science. 1985; 227: 1601-1602
        • Gawin F
        • Kleber H
        Cocaine abuse treatment.
        Arch Gen Psychiatry. 1984; 41: 903-909
        • Innis RB
        • Seibyl JP
        • Scanley BE
        • Laruelle M
        • Abi-Dargham A
        • Wallace E
        • et al.
        Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.
        in: Proc Natl Acad Sci. 90. 1993: 11965-11969
        • Koreen AR
        • Lieberman J
        • Alvir J
        • Mayerhoff D
        • Loebel A
        • Chakos M
        • et al.
        Plasma homovanillic acid levels in first-episode schizophrenia.
        Arch Gen Psychiatry. 1994; 5: 132-138
        • Laruelle M
        • Wallace E
        • Seibyl J
        • Baldwin R
        • Zea-Ponce Y
        • Zoghbi S
        • et al.
        Graphical, kinetic, and equilibrium analyses of in vivo [123I]B-CIT binding to dopamine transporters in healthy human subjects.
        J Cereb Blood Flow Metab. 1994; 14 (1994): 982-994
        • Maas JW
        • Hattox SE
        • Landis DH
        The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenethyleneglycol (MHPG).
        Brain Res. 1976; 118: 167-173
        • Malison R
        • Best S
        • Wallace E
        • vanDyck C
        • Zoghbi S
        • Zea-Ponce Y
        • et al.
        SPECT imaging of dopamine transporters in cocaine dependent and healthy control subjects with [123I]B-CIT.
        J Nucl Med. 1995; 36: 31P
        • Malison R
        • Best S
        • Zoghbi S
        • Zea-Ponce Y
        • Baldwin R
        • Charney D
        • et al.
        SPECT imaging of dopamine transporters during sustained cocaine abstinence with [123I]B-CIT.
        J Nucl Med. 1996; 37: 44P
        • Martin SD
        • Yeragani VK
        • Lodhi R
        • Galloway MP
        Clinical ratings and plasma HVA during cocaine abstinence.
        Biol Psychiatry. 1989; 26: 356-362
        • Mazure CM
        • Bowers Jr, MB
        • Hoffman Jr, F
        • Miller KB
        • Nelson JC
        Plasma catecholamine metabolites in subtypes of major depression.
        Biol Psychiatry. 1987; 22: 1469-1472
        • Mazure CM
        • Nelson JC
        • Jatlow PI
        • Bowers Jr, MB
        Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
        Biol Psychiatry. 1991; 30: 475-482
        • McDougle CJ
        • Price LH
        • Palumbo JM
        • Kosten TR
        • Heninger GR
        • Kleber HD
        Dopaminergic responsivity during cocaine abstinence: a pilot study.
        Psychiatry Res. 1992; 43: 77-85
        • McDougle CJ
        • Black JE
        • Malison RT
        • Zimmerman RC
        • Kosten TR
        • Heninger GR
        • et al.
        Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
        Arch Gen Psychiatry. 1994; 51: 713-718
        • Pickar D
        • Labarca R
        • Doran AR
        • Wolkowitz OM
        • Roy A
        • Breier A
        • et al.
        Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients.
        Arch Gen Psychiatry. 1986; 43: 669-676
        • Satel SL
        • Price LH
        • Palumbo JM
        • McDougle CJ
        • Krystal JH
        • Gawin F
        • et al.
        Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.
        Am J Psychiatry. 1991; 148: 1712-1716
        • Seibyl JP
        • Laruelle M
        • van Dyck CH
        • Wallace E
        • Baldwin RM
        • Zoghbi S
        • et al.
        Reproducibility of Iodine-123-B-CIT SPECT brain measurement of dopamine transporters.
        J Nucl Med. 1996; 37: 222-228
        • Sharma R
        • Javaid J
        • Janicak P
        • Faull K
        • Comaty J
        • Davis JM
        Plasma and CSF HVA before and after pharmacological treatment.
        Psychiatry Res. 1989; 28: 97-104
        • Sherer MA
        Intravenous cocaine: Psychiatric effects, biological mechanisms.
        Biol Psychiatry. 1988; 24: 865-885